A Study of Measuring Oculomotor and Cognitive Performance During Cerebral Hypoxia Using the Oculo-Cognitive Addition Test (OCAT)

Overview

About this study

The purpose of this study is to develop real-time measurements of oculomotor and cognitive performance during Oculo-Cognitive Test (OCAT) to provide early signs of cognitive impairment due to cerebral hypoxia.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Ages 18 to 55 years
Able to give consent

Exclusion Criteria:

Age <18 years and any history of:
- Obstructive or restrictive pulmonary disease
- Cardiovascular disease
- Epilepsy
- Diabetes mellitus
- Chronic headaches or neurological disorders
- Hematological disorders.
No beard (due to need to wear an oronasal mask to breathe through)
No pregnancy

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Jan Stepanek, M.D., M.P.H.	Closed for enrollment

Mayo Clinic Location

Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Jan Stepanek, M.D., M.P.H.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials